Emmaus Life Sciences EMMA
OTC EMMA
$0.05 -0.01 (-16.67%)
At close: Oct 19, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Long-Term Debt Repayments (2010 - 2026)

Updated

Emmaus Life Sciences (EMMA) posted Long-Term Debt Repayments of $1.45 million for Q2 2026, down 9.6% from $1.6 million a year earlier and down 19.5% from the prior quarter.

Analysis

Emmaus Life Sciences (EMMA) Long-Term Debt Repayments (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Long-Term Debt Repayments at Emmaus Life Sciences was $9.28 million, up 93.8% year-over-year; for FY2025, it was $8.88 million, up 97.0% from FY2024.

  • Annual Long-Term Debt Repayments shows a five-year compound annual growth rate of 20.5% (FY2020 to FY2025).
  • In prior years, Emmaus Life Sciences' Long-Term Debt Repayments was $4.51 million in FY2024 (-39.0%), $7.39 million in FY2023 (+308.5%), $1.81 million in FY2022 (-74.9%) and $7.2 million in FY2021 (+105.7%).
  • The Q2 2026 figure stands as the lowest quarterly Long-Term Debt Repayments since Q1 2025.
  • On a year-over-year basis, Long-Term Debt Repayments increased in four of the last eight quarters, with growth averaging 55.1%.
  • The strongest year-over-year quarter for Long-Term Debt Repayments in the past five years was Q4 2025, with growth of 349.5%; the weakest was Q3 2024, with a decline of 69.9%.
  • According to Business Quant data, Long-Term Debt Repayments for the three prior quarters was $1.8 million (Q1 2026), $3.71 million (Q4 2025) and $2.33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.00 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.46 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 17.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Emmaus Life Sciences 3.51 Mn -2.79 Mn 5.97 Mn 1.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.54 Mn
Mar 31, 2026 1.81 Mn
Dec 31, 2025 3.71 Mn
Sep 30, 2025 2.33 Mn
Jun 30, 2025 1.75 Mn
Mar 31, 2025 1.55 Mn
Dec 31, 2024 1.11 Mn
Sep 30, 2024 1.24 Mn
Jun 30, 2024 766,000.00
Mar 31, 2024 2.36 Mn
Dec 31, 2023 2.05 Mn
Sep 30, 2023 3.76 Mn
Jun 30, 2023 1.12 Mn
Mar 31, 2023 570,000.00
Dec 31, 2022 446,000.00
Sep 30, 2022 2.60 Mn
Dec 31, 2021 500,000.00
Jun 30, 2021 235,000.00
Mar 31, 2021 8.04 Mn
Dec 31, 2020 3.02 Mn
API Access

Emmaus Life Sciences Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=EMMA&period=max&api_key=YOUR_API_KEY